Erratum: Modulation of gut microbiota and delayed immunosenescence as a result of syringaresinol consumption in middle-aged mice (Scientific Reports (2016) 6 (39026) DOI: 10.1038/srep39026);Modulation of gut microbiota and delayed immunosenescence as a result of syringaresinol consumption in middle-aged mice

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Cho, Si Young ^a   Kim, Juewon ^a   Lee, Ji Hae ^a   Sim, Ji Hyun ^b   Cho, Dong Hyun ^a   Bae, Il Hong ^a   Lee, Hyunbok ^a   Seol, Min A ^b   Shin, Hyun Mu ^b   Kim, Tae Joo ^b   Kim, Dae Yong ^b   Lee, Su Hyung ^b   Shin, Song Seok ^a   Lm, Sin Hyeog ^c,d   Kim, Hang Rae ^b  

^a AmorePacific Corporation   (South Korea)

^b Seoul National University   (South Korea)

^c Institute for Basic Science   (South Korea)

^d Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; FURAN DERIVATIVE; LIGNAN; SYRINGARESINOL; TRANSCRIPTION FACTOR FKHRL1;

AGING; ANIMAL; AREA UNDER THE CURVE; BIFIDOBACTERIUM; C57BL MOUSE; DRUG EFFECT; FEMALE; IMMUNOLOGY; IMMUNOSENESCENCE; INSTITUTE FOR CANCER RESEARCH MOUSE; INTESTINE FLORA; LACTOBACILLUS; MALE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; T LYMPHOCYTE SUBPOPULATION; VERRUCOMICROBIA;

AGING; ANIMALS; AREA UNDER CURVE; BIFIDOBACTERIUM; CD3 COMPLEX; FEMALE; FORKHEAD BOX PROTEIN O3; FURANS; GASTROINTESTINAL MICROBIOME; IMMUNOSENESCENCE; LACTOBACILLUS; LIGNANS; MALE; MICE, INBRED C57BL; MICE, INBRED ICR; RATS, SPRAGUE-DAWLEY; T-LYMPHOCYTE SUBSETS; VERRUCOMICROBIA;

EID: 85006324099     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep41667     Document Type: Erratum

References (80)

1. Kennedy, B. K., et al. Geroscience: linking aging to chronic disease. Cell 159, 709-713, doi: 10.1016/j.cell.2014.10.039 (2014).
2. Franceschi, C., Campisi, J. Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases. Journals of Gerontology Series a-Biological Sciences and Medical Sciences 69, S4-S9, doi: 10.1093/gerona/glu057 (2014).
3. Fulop, T., et al. Immunosenescence and cancer. Crit Rev Oncog 18, 489-513 (2013).
4. Krupica, T. Jr., Fry, T. J., Mackall, C. L. Autoimmunity during lymphopenia: a two-hit model. Clin Immunol 120, 121-128, doi: 10.1016/j.clim.2006.04.569 (2006).
5. Goronzy, J. J., Weyand, C. M. Understanding immunosenescence to improve responses to vaccines. Nat Immunol 14, 428-436, doi: 10.1038/ni.2588 (2013).
6. Gavazzi, G., Krause, K. H. Ageing and infection. Lancet Infect Dis 2, 659-666 (2002).
7. Goronzy, J. J., Fang, F., Cavanagh, M. M., Qi, Q., Weyand, C. M. Naive T cell maintenance and function in human aging. J Immunol 194, 4073-4080, doi: 10.4049/jimmunol.1500046 (2015).
8. Garg, S. K., et al. Aging is associated with increased regulatory T-cell function. Aging Cell 13, 441-448, doi: 10.1111/acel.12191 (2014).
9. Frasca, D., Blomberg, B. B. Effects of aging on B cell function. Curr Opin Immunol 21, 425-430, doi: 10.1016/j.coi.2009.06.001 (2009).
10. Pinchuk, L. M., Filipov, N. M. Differential effects of age on circulating and splenic leukocyte populations in C57BL/6 and BALB/c male mice. Immun Ageing 5, 1, doi: 10.1186/1742-4933-5-1 (2008).
11. Weiskopf, D., Weinberger, B., Grubeck-Loebenstein, B. The aging of the immune system. Transpl Int 22, 1041-1050, doi: 10.1111/j.1432-2277.2009.00927.x (2009).
12. Nikolich-Zugich, J., Messaoudi, I. Mice and flies and monkeys too: caloric restriction rejuvenates the aging immune system of non-human primates. Exp Gerontol 40, 884-893, doi: 10.1016/j.exger.2005.06.007 (2005).
13. Capri, M., et al. Complexity of anti-immunosenescence strategies in humans. Artif Organs 30, 730-742, doi: 10.1111/j. 1525-1594.2006.00295.x (2006).
14. Adolfsson, O., Huber, B. T., Meydani, S. N. Vitamin E-enhanced IL-2 production in old mice: naive but not memory T cells show increased cell division cycling and IL-2-producing capacity. J Immunol 167, 3809-3817 (2001).
15. Candore, G., et al. Immunosenescence and anti-immunosenescence therapies: the case of probiotics. Rejuvenation Res 11, 425-432, doi: 10.1089/rej.2008.0662 (2008).
16. Messaoudi, I., et al. Delay of T cell senescence by caloric restriction in aged long-lived nonhuman primates. Proc Natl Acad Sci USA 103, 19448-19453, doi: 10.1073/pnas.0606661103 (2006).
17. Pahlavani, M. A. Caloric restriction and immunosenescence: a current perspective. Front Biosci 5, D580-587 (2000).
18. Spaulding, C. C., Walford, R. L., Effros, R. B. Calorie restriction inhibits the age-related dysregulation of the cytokines TNF-alpha and IL-6 in C3B10RF1 mice. Mech Ageing Dev 93, 87-94 (1997).
19. Fontana, L., Partridge, L. Promoting health and longevity through diet: from model organisms to humans. Cell 161, 106-118, doi: 10.1016/j.cell.2015.02.020 (2015).
20. Biagi, E., et al. Ageing and gut microbes: perspectives for health maintenance and longevity. Pharmacol Res 69, 11-20, doi: 10.1016/j. phrs.2012.10.005 (2013).
21. Tien, M. T., et al. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 176, 1228-1237 (2006).
22. Ouwehand, A. C., et al. Bifidobacterium microbiota and parameters of immune function in elderly subjects. FEMS Immunol Med Microbiol 53, 18-25, doi: 10.1111/j.1574-695X.2008.00392.x (2008).
23. Ibrahim, F., et al. Probiotics and immunosenescence: cheese as a carrier. FEMS Immunol Med Microbiol 59, 53-59, doi: 10.1111/j.1574-695X.2010.00658.x (2010).
24. Zhang, C., et al. Structural modulation of gut microbiota in life-long calorie-restricted mice. Nat Commun 4, 2163, doi: 10.1038/ncomms3163 (2013).
25. Smeds, A. I., Eklund, P. C., Willfor, S. M. Content, composition, and stereochemical characterisation of lignans in berries and seeds. Food Chem 134, 1991-1998, doi: 10.1016/j.foodchem.2012.03.133 (2012).
26. Yamazaki, T., Shimosaka, S., Sasaki, H., Tukiyama, T., Tokiwa, T. (+ )-Syringaresinol-di-O-beta-D-glucoside, a phenolic compound from Acanthopanax senticosus Harms, suppresses proinflammatory mediators in SW982 human synovial sarcoma cells by inhibiting activating protein-1 and/or nuclear factor-kappaB activities. Toxicol. In Vitro. 21, 1530-1537 (2007).
27. Chung, B. H., et al. Syringaresinol causes vasorelaxation by elevating nitric oxide production through the phosphorylation and dimerization of endothelial nitric oxide synthase. Exp. Mol. Med. 44, 191-201 (2012).
28. Lajter, I., et al. Inhibition of COX-2 and NF-kappaB1 Gene Expression, NO Production, 5-LOX, and COX-1 and COX-2 Enzymes by Extracts and Constituents of Onopordum acanthium. Planta Med 81, 1270-1276, doi: 10.1055/s-0035-1546242 (2015).
29. Heinonen, S., et al. In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem 49, 3178-3186 (2001).
30. Cho, S., et al. Syringaresinol protects against hypoxia/reoxygenation-induced cardiomyocytes injury and death by destabilization of HIF-1alpha in a FOXO3-dependent mechanism. Oncotarget 6, 43-55 (2015).
31. Cho, S. Y., Cho, M., Seo, D. B., Lee, S. J., Suh, Y. Identification of a small molecule activator of SIRT1 gene expression. Aging (Albany NY) 5, 174-182 (2013).
32. van der Horst, A., Burgering, B. M. Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol 8, 440-450, doi: 10.1038/nrm2190 (2007).
33. Hedrick, S. M., Hess Michelini, R., Doedens, A. L., Goldrath, A. W., Stone, E. L. FOXO transcription factors throughout T cell biology. Nat Rev Immunol 12, 649-661, doi: 10.1038/nri3278 (2012).
34. Kerdiles, Y. M., et al. Foxo transcription factors control regulatory T cell development and function. Immunity 33, 890-904, doi: 10.1016/j.immuni.2010.12.002 (2010).
35. Peng, S. L. Foxo in the immune system. Oncogene 27, 2337-2344, doi: 10.1038/onc.2008.26 (2008).
36. Miller, R. A., Chrisp, C., Galecki, A. CD4 memory T cell levels predict life span in genetically heterogeneous mice. FASEB J 11, 775-783 (1997).
37. Miller, R. A., Chrisp, C. T cell subset patterns that predict resistance to spontaneous lymphoma, mammary adenocarcinoma, and fibrosarcoma in mice. J Immunol 169, 1619-1625 (2002).
38. Rodgers, J. T., et al. Nutrient control of glucose homeostasis through a complex of PGC-1 alpha and SIRT1. Nature 434, 113-118, doi: 10.1038/nature03354 (2005).
39. Sun, L., et al. A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 33, 1925-1932, doi: 10.2337/dc10-0340 (2010).
40. Martinet, K. Z., Bloquet, S., Bourgeois, C. Ageing combines CD4 T cell lymphopenia in secondary lymphoid organs and T cell accumulation in gut associated lymphoid tissue. Immunity, Ageing 11, doi: Artn 810.1186/1742-4933-11-8 (2014).
41. Gardner, E. M. Caloric restriction decreases survival of aged mice in response to primary influenza infection. J Gerontol A Biol Sci Med Sci 60, 688-694 (2005).
42. Goldberg, E. L., et al. Lifespan-extending caloric restriction or mTOR inhibition impair adaptive immunity of old mice by distinct mechanisms. Aging Cell 14, 130-138, doi: 10.1111/acel.12280 (2015).
43. Wakikawa, A., Utsuyama, M., Wakabayashi, A., Kitagawa, M., Hirokawa, K. Age-related alteration of cytokine production profile by T cell subsets in mice: a flow cytometric study. Exp Gerontol 34, 231-242 (1999).
44. Thoman, M. L., Weigle, W. O. Lymphokines and aging: interleukin-2 production and activity in aged animals. J Immunol 127, 2102-2106 (1981).
45. Jagger, A., Shimojima, Y., Goronzy, J. J., Weyand, C. M. Regulatory T cells and the immune aging process: a mini-review. Gerontology 60, 130-137, doi: 10.1159/000355303 (2014).
46. Chougnet, C. A., et al. A major role for Bim in regulatory T cell homeostasis. J Immunol 186, 156-163, doi: 10.4049/jimmunol.1001505 (2011).
47. Bouillet, P., et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286, 1735-1738 (1999).
48. Herold, M. J., et al. Foxo-mediated Bim transcription is dispensable for the apoptosis of hematopoietic cells that is mediated by this BH3-only protein. EMBO Rep 14, 992-998, doi: 10.1038/embor.2013.152 (2013).
49. Kau, A. L., Ahern, P. P., Griffin, N. W., Goodman, A. L., Gordon, J. I. Human nutrition, the gut microbiome and the immune system. Nature 474, 327-336, doi: 10.1038/nature10213 (2011).
50. Lozupone, C., Lladser, M. E., Knights, D., Stombaugh, J., Knight, R. UniFrac: an effective distance metric for microbial community comparison. ISME J 5, 169-172, doi: 10.1038/ismej.2010.133 (2011).
51. Claesson, M. J., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA 108 Suppl 1, 4586-4591, doi: 10.1073/pnas.1000097107 (2011).
52. Mariat, D., et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 9, 123, doi: 10.1186/1471-2180-9-123 (2009).
53. Xiao, S., et al. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol Ecol 87, 357-367, doi: 10.1111/1574-6941.12228 (2014).
54. Zweigner, J., Schumann, R. R., Weber, J. R. The role of lipopolysaccharide-binding protein in modulating the innate immune response. Microbes Infect 8, 946-952, doi: 10.1016/j.micinf.2005.10.006 (2006).
55. Huber, V. C., et al. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza. Clin Vaccine Immunol 13, 981-990, doi: 10.1128/CVI.00156-06 (2006).
56. Harper, J. M., Galecki, A. T., Burke, D. T., Miller, R. A. Body weight, hormones and T cell subsets as predictors of life span in genetically heterogeneous mice. Mechanisms of Ageing and Development 125, 381-390, doi: 10.1016/j.mad.2004.03.003 (2004).
57. Sharma, S., Dominguez, A. L., Lustgarten, J. High accumulation of T regulatory cells prevents the activation of immune responses in aged animals. J Immunol 177, 8348-8355 (2006).
58. Fink, C., et al. Intestinal FoxO signaling is required to survive oral infection in Drosophila. Mucosal Immunol, doi: 10.1038/mi.2015.112 (2015).
59. Hesp, K., Smant, G., Kammenga, J. E. Caenorhabditis elegans DAF-16/FOXO transcription factor and its mammalian homologs associate with age-related disease. Exp Gerontol 72, 1-7, doi: 10.1016/j.exger.2015.09.006 (2015).
60. Lin, L., Hron, J. D., Peng, S. L. Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21, 203-213, doi: 10.1016/j.immuni.2004.06.016 (2004).
61. Morris, B. J., Willcox, D. C., Donlon, T. A., Willcox, B. J. FOXO3: A Major Gene for Human Longevity-A Mini-Review. Gerontology 61, 515-525, doi: 10.1159/000375235 (2015).
62. Claesson, M. J., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488, 178-184, doi: 10.1038/nature11319 (2012).
63. Perez Martinez, G., Bauerl, C., Collado, M. C. Understanding gut microbiota in elderly's health will enable intervention through probiotics. Benef Microbes 5, 235-246, doi: 10.3920/BM2013.0079 (2014).
64. Thomas, F., Hehemann, J. H., Rebuffet, E., Czjzek, M., Michel, G. Environmental and gut bacteroidetes: the food connection. Front Microbiol 2, 93, doi: 10.3389/fmicb.2011.00093 (2011).
65. Valdez, Y., Brown, E. M., Finlay, B. B. Influence of the microbiota on vaccine effectiveness. Trends Immunol 35, 526-537, doi: 10.1016/j.it.2014.07.003 (2014).
66. Biagi, E., et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 5, e10667, doi: 10.1371/journal.pone.0010667 (2010).
67. Drago, L., Toscano, M., Rodighiero, V., De Vecchi, E., Mogna, G. Cultivable and pyrosequenced fecal microflora in centenarians and young subjects. J Clin Gastroenterol 46 Suppl, S81-84, doi: 10.1097/MCG.0b013e3182693982 (2012).
68. Tsai, Y. T., Cheng, P. C., Pan, T. M. The immunomodulatory effects of lactic acid bacteria for improving immune functions and benefits. Appl Microbiol Biotechnol 96, 853-862, doi: 10.1007/s00253-012-4407-3 (2012).
69. Hori, T., Kiyoshima, J., Shida, K., Yasui, H. Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clin Diagn Lab Immunol 9, 105-108 (2002).
70. Bayry, J. Regulatory T cells as adjuvant target for enhancing the viral disease vaccine efficacy. Virusdisease 25, 18-25, doi: 10.1007/s13337-013-0187-3 (2014).
71. Wang, S. M., Tsai, M. H., Lei, H. Y., Wang, J. R., Liu, C. C. The regulatory T cells in anti-influenza antibody response post influenza vaccination. Hum Vaccin Immunother 8, 1243-1249, doi: 10.4161/hv.21117 (2012).
72. Shin, N. R., Whon, T. W., Bae, J. W. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol 33, 496-503, doi: 10.1016/j.tibtech.2015.06.011 (2015).
73. Oh, J. Z., et al. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity 41, 478-492, doi: 10.1016/j.immuni.2014.08.009 (2014).
74. Bordone, L., Guarente, L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol 6, 298-305, doi: 10.1038/nrm1616 (2005).
75. Kitada, M., Koya, D. SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential. Diabetes Metab J 37, 315-325, doi: 10.4093/dmj.2013.37.5.315 (2013).
76. Stephenson, I., Wood, J. M., Nicholson, K. G., Charlett, A., Zambon, M. C. Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine. Virus Res 103, 91-95, doi: 10.1016/j. virusres.2004.02.019 (2004).
77. Chun, J., Kim, K. Y., Lee, J. H., Choi, Y. The analysis of oral microbial communities of wild-type and toll-like receptor 2-deficient mice using a 454 GS FLX Titanium pyrosequencer. BMC Microbiol 10, 101, doi: 10.1186/1471-2180-10-101 (2010).
78. Finn, R. D., Clements, J., Eddy, S. R. HMMER web server: interactive sequence similarity searching. Nucleic Acids Res 39, W29-37, doi: 10.1093/nar/gkr367 (2011).
79. Kim, O. S., et al. Introducing EzTaxon-e: a prokaryotic 16S rRNA gene sequence database with phylotypes that represent uncultured species. Int J Syst Evol Microbiol 62, 716-721, doi: 10.1099/ijs.0.038075-0 (2012).
80. Schloss, P. D., et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75, 7537-7541, doi: 10.1128/AEM.01541-09 (2009).